We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PAVS:NASDAQParanovus Entertainment Technology Ltd. Analysis

Data as of 2026-04-23 - not real-time

$1.42

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Paranovus Entertainment Technology Ltd. is trading well below its short‑term moving averages, with the current price sitting far under both the 20‑day and 50‑day SMA lines, reinforcing a bearish price trend. The RSI has slipped into oversold territory, suggesting that momentum may be exhausted and a short‑term bounce could be possible. Meanwhile, the MACD histogram is positive, indicating a nascent bullish divergence that aligns with the increasing volume trend. Volatility is extreme, and the beta reading points to heightened sensitivity to market swings, amplifying short‑term risk.
Fundamentally, the company shows explosive revenue growth but remains deeply loss‑making, with negative operating and profit margins and a high debt‑to‑equity ratio. Despite operating losses, free cash flow is positive and the balance sheet holds a solid cash cushion relative to debt. The price‑to‑book ratio is a fraction of one, and the discounted cash‑flow model implies a fair value many times the current market price, painting a picture of severe undervaluation. However, the lack of dividend and persistent earnings deficits temper optimism, making the stock a high‑risk, high‑potential play.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price deep below key moving averages
  • RSI indicating oversold conditions
  • MACD histogram turning positive amid rising volume

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • substantial undervaluation relative to DCF fair value
  • extremely low price‑to‑book ratio
  • positive free cash flow despite earnings losses

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • ongoing revenue growth potential in AI‑driven entertainment
  • high debt burden and negative profitability
  • market sentiment driven by extreme greed index

Key Metrics & Analysis

Financial Health

Revenue Growth18033.40%
Profit Margin-54.84%
ROE-21.54%
ROA-3.13%
Debt/Equity10.83
P/B Ratio0.0
Op. Cash Flow$-1862427
Free Cash Flow$2.3M

Technical Analysis

TrendBearish
RSI31.5
Support$1.42
Resistance$3.36
MA 20$1.86
MA 50$8.48
MA 200$484.95
MACDBullish
VolumeIncreasing
Fear & Greed Index86.36

Valuation

Fair Value$84.35
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.43
Volatility398.21%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.